[1] Hansen KJ,
Edwards MS,
Craven TE,
Cherr GS,
Jackson Sa,Appel RG,
Burke Gl,
Dean RH.
Prevalence Of Renovascular Disease In The Elderly: A Population Based Study.
J Vasc Surg 36:443–451,
2002.
[2] Safian RD,Textor SC.
Renal-artery stenosis. N Engl J Med.
2001 Feb 8;344(6):431-42.
[3] Hirsch AT, Haskal ZJ, Herzter NR et al.
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity,
renal,
mesenteric,
and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery,
Society for Cardiovascular Angiography and Interventions,
Society for Vascular Medicine and Biology,
Society of Interventional Radiology,
and the ACC/AHA Task Force on Practice Guidelines.
J Am Kidney Dis 2000;35:573-87.
[4] Chrysochou C, KalraPA.
Current management of atherosclerotic renovascular disease--what have we learned from ASTRAL? Nephron Clin Pract. 2010;115(1):c73-81.
Epub 2010 Feb 20.
[5] Topaz O.
Stenting for renal artery stenosis: effects of contested data on opposing management strategies.Catheter Cardiovasc Interv. 2010 Jan 1;75(1):11-3.
[6]The ASTRAL investigators (2009).
Revascularization versus medical therapy for renal-artery stenosis.N EnglJ Med 2009 Nov 12;361(20):1953-62.
[7] Cooper JC,
Murphy TP,
Matsumoto A,
Steffes M,
Cohen DJ.
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J. 2006 Jul;152(1):59-66.